Moderna (MRNA) EBIT Margin Growth (1y) (2018 - 2026)
Moderna (MRNA) EBIT Margin Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,552.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,536.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -170.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1,049.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Moderna | 22.52 Bn | 17.32 Bn | -566.00 Mn | 61,541.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 61,541.00 |
| Dec 31, 2025 | 258.00 |
| Sep 30, 2025 | -2,183.00 |
| Jun 30, 2025 | -7,317.00 |
| Mar 31, 2025 | -21,414.00 |
| Dec 31, 2024 | -12,920.00 |
| Sep 30, 2024 | 10,613.00 |
| Jun 30, 2024 | -2,283.00 |
| Mar 31, 2024 | -73,843.00 |
| Dec 31, 2023 | -3,086.00 |
| Sep 30, 2023 | -14,455.00 |
| Jun 30, 2023 | -59,426.00 |
| Mar 31, 2023 | -8,934.00 |
| Dec 31, 2022 | -4,395.00 |
| Sep 30, 2022 | -3,694.00 |
| Jun 30, 2022 | -1,880.00 |
| Mar 31, 2022 | 432.00 |
| Dec 31, 2021 | 12,319.00 |
| Sep 30, 2021 | 22,129.00 |
| Jun 30, 2021 | 25,242.00 |